THE SERIOUS TALK - 7
In this presentation Dr. Troll discusses ClaretBio solution to NGS of high molecular weight DNA derived from FFPE samples. He covers the features of our DNA fragmentation reagent ForShear™
Kelly Harkins (CEO, Claret Bioscience and Astrea Forensics): "Get more from less: The SRSLY sequencing preparation method"
In this presentation Dr. Troll discusses ClaretBio solution to NGS of high molecular weight DNA derived from FFPE samples. He covers the features of our DNA fragmentation reagent ForShear™
In this presentation Dr. Katie Miller discusses the finding of the study conducted at Nationwide Children’s Hospital that pre-zygotic aneuploidy followed by post-zygotic partial reversion leads to a recurrent form of brain mosaicism-related epilepsy. Genomic analysis showed evidence of an extra, parentally-derived chromosome 1q in five of six patient brain tissues, which was not present in blood or buccal tissue – as evidenced by high-depth targeted sequencing of residual DNA using ClaretBio’s SRSLY